What Researchers Did
Researchers describe a case where a patient with severe rattlesnake envenomation received standard antivenom treatment supplemented with hyperbaric oxygen therapy.
What They Found
A patient with Grade 3 out of 3 rattlesnake envenomation received six daily hyperbaric oxygen treatments at 2.4 atmospheres absolute for 75 minutes each. The therapy was well tolerated, and long-term follow-up suggested it was reasonably and effectively administered in the post-acute phase.
What This Means for Canadian Patients
For Canadian patients experiencing severe snake envenomation, this case suggests that adjunctive hyperbaric oxygen therapy could potentially be considered to help manage lesions and prevent complications. However, given the rarity of such severe envenomations in Canada, this remains an experimental approach requiring further research.
Canadian Relevance
This case report has no direct Canadian relevance as the specific type of snake envenomation described is not common in Canada.
Study Limitations
As a case report, this study's findings are limited to a single patient and cannot be generalized to a broader population.